Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Blaickner

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cancer Biotherapy & Radiopharmaceuticals|December 30, 2008
Diversification of existing reference phantoms in nuclear medicine: Calculation of specific absorbed fractions for 21 mathematical phantoms and validation through dose estimates resulting from the administration of (18)F-FDGMatthias Blaickner, Peter Kindl
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|July 16, 2017
Adaption of a PIN-diode detector as an online neutron monitor for the thermal column of the TRIGA research reactorTobias Schmitz, Matthias Blaickner
Radiation Protection Dosimetry|March 20, 2013
Measurements of occupational and patient exposure as well as image quality for two C-armsMatthias Blaickner, Johannes Neuwirth
PET Clinics|July 18, 2014
Relevance of PET for pretherapeutic prediction of doses in peptide receptor radionuclide therapyMatthias Blaickner, Richard P Baum
Medical Physics|December 10, 2009
Discrete beta dose kernel matrices for nuclides applied in targeted radionuclide therapy (TRT) calculated with MCNP5Dora Reiner, Matthias Blaickner, Frank Rattay
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 11, 2017
Treatment plan optimization and robustness of <sup>106</sup>Ru eye plaque brachytherapy using a novel software toolGerd Heilemann, Lukas Fetty, Martin Dulovits, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 18, 2018
Retina dose as a predictor for visual acuity loss in <sup>106</sup>Ru eye plaque brachytherapy of uveal melanomasGerd Heilemann, Lukas Fetty, Matthias Blaickner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 16, 2016
Whole-Body Distribution and Radiation Dosimetry of 11C-Elacridar and 11C-Tariquidar in HumansMartin Bauer, Matthias Blaickner, Cécile Philippe, et al.
Clinical Nuclear Medicine|July 1, 2020
Dose Calculations and Dose-Effect Relationships in 177Lu-PSMA I&T Radionuclide Therapy for Metastatic Castration-Resistant Prostate CancerSandra Barna, Alexander R Haug, Markus Hartenbach, et al.
Medical Physics|November 6, 2014
Confirmation of a realistic reactor model for BNCT dosimetry at the TRIGA MainzMarkus Ziegner, Tobias Schmitz, Rustam Khan, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancer Biotherapy & Radiopharmaceuticals|December 30, 2008
Diversification of existing reference phantoms in nuclear medicine: Calculation of specific absorbed fractions for 21 mathematical phantoms and validation through dose estimates resulting from the administration of (18)F-FDGMatthias Blaickner, Peter Kindl
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|July 16, 2017
Adaption of a PIN-diode detector as an online neutron monitor for the thermal column of the TRIGA research reactorTobias Schmitz, Matthias Blaickner
Radiation Protection Dosimetry|March 20, 2013
Measurements of occupational and patient exposure as well as image quality for two C-armsMatthias Blaickner, Johannes Neuwirth
PET Clinics|July 18, 2014
Relevance of PET for pretherapeutic prediction of doses in peptide receptor radionuclide therapyMatthias Blaickner, Richard P Baum
Medical Physics|December 10, 2009
Discrete beta dose kernel matrices for nuclides applied in targeted radionuclide therapy (TRT) calculated with MCNP5Dora Reiner, Matthias Blaickner, Frank Rattay
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 11, 2017
Treatment plan optimization and robustness of <sup>106</sup>Ru eye plaque brachytherapy using a novel software toolGerd Heilemann, Lukas Fetty, Martin Dulovits, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|February 18, 2018
Retina dose as a predictor for visual acuity loss in <sup>106</sup>Ru eye plaque brachytherapy of uveal melanomasGerd Heilemann, Lukas Fetty, Matthias Blaickner, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 16, 2016
Whole-Body Distribution and Radiation Dosimetry of 11C-Elacridar and 11C-Tariquidar in HumansMartin Bauer, Matthias Blaickner, Cécile Philippe, et al.
Clinical Nuclear Medicine|July 1, 2020
Dose Calculations and Dose-Effect Relationships in 177Lu-PSMA I&T Radionuclide Therapy for Metastatic Castration-Resistant Prostate CancerSandra Barna, Alexander R Haug, Markus Hartenbach, et al.
Medical Physics|November 6, 2014
Confirmation of a realistic reactor model for BNCT dosimetry at the TRIGA MainzMarkus Ziegner, Tobias Schmitz, Rustam Khan, et al.
Pageof 2